The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma
<p>Abstract</p> <p>Background</p> <p>Gallbladder cancer is the most common billiary tract malignancy and carries a very poor prognosis. Somatostatin was recently shown to play an important role in the development of various tumors. In the current study, we evaluated the...
| Glavni autori: | , , , |
|---|---|
| Format: | Članak |
| Jezik: | English |
| Izdano: |
BMC
2007-07-01
|
| Serija: | BMC Cancer |
| Online pristup: | http://www.biomedcentral.com/1471-2407/7/125 |